Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study (Q45072930)

9 December 2017

title

Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study (English)

1 reference

inflammatory bowel diseases

9 December 2017

main subject

1 reference

Fabrizio Scatena

1 reference

9 December 2017

Rodolfo Sacco

1 reference

9 December 2017

Antonio Romano

1 reference

9 December 2017

Alessandro Mazzoni

1 reference

9 December 2017

Marco Bertini

1 reference

9 December 2017

Graziana Federici

1 reference

9 December 2017

Salvatore Metrangolo

1 reference

9 December 2017

Giuseppe Parisi

1 reference

9 December 2017

Cecilia Nencini

1 reference

9 December 2017

Celeste Giampietro

1 reference

9 December 2017

Michele Bertoni

1 reference

9 December 2017

Emanuele Tumino

1 reference

9 December 2017

Giampaolo Bresci

1 reference

9 December 2017

publication date

17 July 2013

1 reference

Journal of Crohn's and Colitis

9 December 2017

published in

1 reference

9 December 2017

1 reference

9 December 2017

1 reference

9 December 2017

page(s)

e692-7

1 reference

5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Frequency of glucocorticoid resistance and dependency in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Current and emerging drugs for the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Medical management of Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: Our experience with a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Current therapeutic apheresis technologies for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Long-term prognosis of patients with ulcerative colitis treated with cytapheresis therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

From randomized controlled trials to observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.06.012

10.1016/J.CROHNS.2013.06.012

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference